Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma

We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rare Tumors
Main Authors: Attia, Steven, Okuno, Scott H., Robinson, Steven I., Webber, Nicholas P., Indelicato, Daniel J., Jones, Robin L., Bagaria, Sanjay P., Sherman, Courtney, Kozak, Kevin R., Cortese, Cherise M., McFarland, Thomas, Trent, Jonathan C., Maki, Robert G.
Formato: Artigo
Idioma:Inglês
Publicado em: PAGEPress Publications, Pavia, Italy 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508650/
https://ncbi.nlm.nih.gov/pubmed/26266019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2015.5992
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados